Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 35 Lymphoid 31 Myeloid 8 Plasma cell 7 Breast 7 Tumor-Agnostic 5 Thoracic 4 Gastrointestinal 4 Classical hematology 2 CNS 2 Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 805 Uterine Cervical Neoplasms 412 Fallopian Tube Neoplasms 289 Endometrial Neoplasms 287 Carcinoma, Ovarian Epithelial 252 Neoplasms 95 Recurrence 83 Breast Neoplasms 83 Peritoneal Neoplasms 66 Uterine Neoplasms 55 Colorectal Neoplasms 55 Uterine Cervical Dysplasia 50 Sarcoma 49 Vulvar Neoplasms 47 Carcinoma, Non-Small-Cell Lung 45 Neoplasm Metastasis 44 Stomach Neoplasms 42 Pancreatic Neoplasms 36 Melanoma 34 Testicular Neoplasms 32 Lung Neoplasms 32 Prostatic Neoplasms 29 Vaginal Neoplasms 28 Papillomavirus Infections 25 Carcinoma 25 Head and Neck Neoplasms 23 Esophageal Neoplasms 23 Carcinoma, Renal Cell 23 Small Cell Lung Carcinoma 22 Urinary Bladder Neoplasms 21

Interventions

Neoadjuvant Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm, Residual × Gynecologic × Clear all

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡